Dysfunctional cuffed tunneled dialysis catheter.
Conditions
Interventions
Intervention 1: Intervention group: Dialysis patients with a tunneled cuffed catheter are given one 10 mg rivaroxaban tablet daily. Patients are followed up at one, three, and six month intervals, and
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ESRD patients who are candidates for Tunneled hemodialysis catheter placement as a permanent hemodialysis access
Exclusion criteria
Exclusion criteria: Presence of a coagulation disorder Two weight ranges (less than 50 kg and more than 150 kg) Receiving anticoagulant medication for another reason, such as cardiac DVT, atrial fibrillation, or an artificial heart valve Untreated malignant lesion of the central nervous system (CNS) Active lesion or active malignancy in the GI and GV system Platelet count less than 70,000
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Thrombosis of cuffed catheter with tunneled dialysis. Timepoint: one month and three months and six months. Method of measurement: Catheter patency rates in the first, third, and sixth months after catheter insertion and cases of catheter dysfunction due to intraluminal thrombosis in both intervention and control groups. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Jamal Jalili Shahri
Mashhad University of Medical Sciences
Outcome results
None listed